These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12928147)

  • 1. [Botulism toxin in practice].
    Durand A; Serment G
    Ann Readapt Med Phys; 2003 Jul; 46(6):386-8. PubMed ID: 12928147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modern non-cosmetic treatment with botulinum toxins].
    Straube A
    Internist (Berl); 2017 Dec; 58(12):1332-1340. PubMed ID: 29030680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A in anal fissure: why does it work?
    Jost WH; Aoki KR
    Dis Colon Rectum; 2004 Feb; 47(2):257-8. PubMed ID: 15043302
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Rajkumar GN; Conn IG
    Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin A: its expanding role in dermatology and esthetics.
    Said S; Meshkinpour A; Carruthers A; Carruthers J
    Am J Clin Dermatol; 2003; 4(9):609-16. PubMed ID: 12926979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
    Matarasso SL
    Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
    Glogau RG
    Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botox and Dysport are distinct.
    Madaliński M
    Endoscopy; 2000 Jun; 32(6):502-3. PubMed ID: 10863924
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handling botulinum toxins: an updated literature review.
    Trindade De Almeida AR; Secco LC; Carruthers A
    Dermatol Surg; 2011 Nov; 37(11):1553-65. PubMed ID: 21777338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.
    Herschorn S; Gajewski J; Ethans K; Corcos J; Carlson K; Bailly G; Bard R; Valiquette L; Baverstock R; Carr L; Radomski S
    J Urol; 2011 Jun; 185(6):2229-35. PubMed ID: 21497851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.